Articles by Calisha Myers
Juvaris completes $25M close of series B
Adjuvant vaccines developer Juvaris BioTherapeutics has completed the first close of a Series B round. The Burlingame, CA-based company says it will use the capital to advance its technology platform
MedImmune: Vaccine ready to go at month's end
MedImmune, which began clinical trials for its swine flu vaccine last month, says the inhaled vaccine could be ready by the end of September. The AstraZeneca subsidiary is now waiting on the FDA to
Vaccine for Hendra virus 15 years, $1B away
A human vaccine to guard against the Hendra virus, which recently caused the death of an Australian veterinarian, may be 15 years and one billion dollars away, the renowned scientist Ian Frazer tells
No H1N1 vaccine contracts for India
Some are questioning India's response to the swine flu pandemic. While many countries have been buying up vaccines before they have even been produced, Indian officials continue to watch from the
Swine flu news roundup
There's new information on swine flu and the companies racing to produce vaccines everyday. Here's a roundup of recent announcements.
GlaxoSmithKline announced that in the past two weeks it has
Inovio's shares boosted on positive H1N1 trials
After a year of trading below $1, shares of Inovio Biomedical soared to $3.18 yesterday. The revival was sparked by the San Diego based company's announcement of positive results from animal studies
MedImmune races ahead to deliver on H1N1 contracts
The U.S. has ordered 195 million doses of swine flu vaccine from five different developers. While many companies are reportedly having trouble growing enough of the H1N1 virus to produce ample doses
CSL begins first human trials of H1N1 vaccine
The first human trial of an H1N1 vaccine began Wednesday. Melbourne, Australia-based developer CSL has launched a human trial of its experimental H1N1 vaccine in partnership with the clinical
GSK begins phase III global trial for malaria vax
GlaxoSmithKline is pushing forward with the final stages of pre-approval development of its malaria vaccine candidate Mosquirix. Scientists began injecting 1,200 infants and children involved in its
Swine flu continues to spread in US
The U.S. has experienced the second highest rate of swine flu infection with 66 confirmed cases as of Wednesday morning. The virus has reached New York, Kansas, Ohio, Texas, Indiana and California.
